GeneDx Holdings Corp. Debt Issuance Costs, Noncurrent, Net
GeneDx Holdings Corp. (WGS) had Debt Issuance Costs, Noncurrent, Net of $3.16 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes
us-gaap:DeferredFinanceCostsNoncurrentNet · last filed 2026-08-03
- 2026-06-30: Debt Issuance Costs, Noncurrent, Net $3.16M.
- 2026-03-31: Debt Issuance Costs, Noncurrent, Net $3.27M.
- 2025-12-31: Debt Issuance Costs, Noncurrent, Net $1.82M.
- 2025-09-30: Debt Issuance Costs, Noncurrent, Net $2.04M.
| Period end | Debt Issuance Costs, Noncurrent, Net |
|---|---|
| 2026-06-30 | $3.16M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $3.27M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $1.82M 10-K · filed 2026-02-23 |
| 2025-09-30 | $2.04M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $2.24M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $2.44M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $2.63M 10-K · filed 2025-02-20 |
| 2024-09-30 | $2.81M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $2.99M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $3.16M 10-Q · filed 2024-04-29 |
| 2023-12-31 | $3.06M 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |